Impaler Pharmaceuticals Private Limited
About Impaler Pharmaceuticals Private Limited
Data last updated:
Impaler Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U52100MH2017PTC291432. Its GSTIN is 27AAECI3884P1ZT (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nikhil Chandramani Meshram (Managing Director) and Chandramani Suryabhan Meshram.
Its last annual general meeting (AGM) was held on 28 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 680 Plot No 12 – A Rambag Layout Behind Shushila, Nagpur, Maharashtra, India – 440003.
As per the financials filed for FY 2020, the company reported a revenue of ₹5.42 Lakh, a decline of 58% compared to the previous year. For the same year it recorded a net profit of ₹4,441 (net margin 0.8%) and EBITDA of ₹6,002 (EBITDA margin 1.1%).
As per MCA filings, the company has open charges of ₹2 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address680 Plot No 12 – A Rambag Layout Behind Shushila, Nagpur, Maharashtra, India – 440003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Impaler Pharmaceuticals Private Limited
The main business activity of Impaler Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Impaler Pharmaceuticals Private Limited FY 2020 filings available
Impaler Pharmaceuticals Private Limited reported revenue of ₹5.42 Lakh (down 58% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Impaler Pharmaceuticals Private Limited
Revenue fell 58% in the latest year. EBITDA rose 2% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Impaler Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹5.42 Lakh | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹6,002 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4,441 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Impaler Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.1% | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Impaler Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Impaler Pharmaceuticals Private Limited
Impaler Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sushvin Pharmaceuticals Private Limited | ₹5.49 Lakh (FY 2022) | •••• | •••• | -22.0% | •••• | Nallasopara East, Maharashtra, India |
| Unicus Pharmaceuticals Private Limited | ₹5.49 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Grochem Pharmaceuticals Private Limited | ₹5.47 Lakh (FY 2025) | •••• | •••• | 9178.0% | •••• | New Delhi, Delhi, India |
| Calyptro Pharmaceuticals Private Limited | ₹5.46 Lakh (FY 2024) | •••• | •••• | -43.0% | •••• | Pratapgarh, Uttar Pradesh, India |
| Fulbert Pharmaceuticals Private Limited | ₹5.44 Lakh (FY 2018) | •••• | •••• | 44.0% | •••• | Surat, Gujarat, India |
| Impaler Pharmaceuticals Private Limited this company | ₹5.42 Lakh (FY 2020) | •••• | •••• | -58.0% | •••• | Nagpur, Maharashtra, India |
| Nibin Pharmaceuticals Private Limited | ₹5.41 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Ahmedabad, Gujarat, India |
| Segmed Pharmaceuticals Private Limited | ₹5.4 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Uttar Pradesh, India |
| Daphne Pharmaceuticals Private Limited | ₹5.39 Lakh (FY 2023) | •••• | •••• | -55.0% | •••• | Bangalore, Karnataka, India |
| Whorl Pharmaceuticals Private Limited | ₹5.39 Lakh (FY 2024) | •••• | •••• | 36.0% | •••• | New Delhi, Delhi, India |
| Macllay Pharmaceuticals Private Limited | ₹5.38 Lakh (FY 2016) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Impaler Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Impaler Pharmaceuticals Private Limited
Impaler Pharmaceuticals Private Limited is audited by AMIT W DHORE & CO for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AMIT W DHORE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Impaler Pharmaceuticals Private Limited
Impaler Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandramani Suryabhan Meshram | Additional Director | 26 Nov 2020 | 5 Years 10 Months | Current |
| Shailja Chandramani Meshram | Additional Director | 05 Dec 2020 | 5 Years 10 Months | Current |
| Nikhil Chandramani Meshram | Managing Director | 20 Feb 2017 | 9 Years 7 Months | Current |
Ownership and Shareholding of Impaler Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Impaler Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 2017 | Syndicate Bank | ₹2 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Impaler Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Impaler Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Impaler Pharmaceuticals Private Limited
Impaler Pharmaceuticals Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Neha Chandramani Meshram ceased to be Director on 19 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for Impaler Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Impaler Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Impaler Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Impaler Pharmaceuticals Private Limited
Impaler Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECI3884P1ZT | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Impaler Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impaler Pharmaceuticals Private Limited
Impaler Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2017 (9+ years old) and is registered under CIN U52100MH2017PTC291432.
Impaler Pharmaceuticals reported revenue of ₹5.42 Lakh for FY 2020 (down 58% YoY).
Impaler Pharmaceuticals has 3 current directors:
- Nikhil Chandramani Meshram - Managing Director
- Chandramani Suryabhan Meshram - Additional Director
- Shailja Chandramani Meshram - Additional Director
Impaler Pharmaceuticals reported a net profit of ₹4,441 (net margin 0.8%) and EBITDA of ₹6,002 (EBITDA margin 1.1%) for FY 2020, as per its filed financial statements.
The GSTIN of Impaler Pharmaceuticals is 27AAECI3884P1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Impaler Pharmaceuticals is U52100MH2017PTC291432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Impaler Pharmaceuticals was incorporated on 20 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Impaler Pharmaceuticals by revenue are Sushvin Pharmaceuticals Private Limited, Unicus Pharmaceuticals Private Limited, Grochem Pharmaceuticals Private Limited, Calyptro Pharmaceuticals Private Limited, Fulbert Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Neha Chandramani Meshram ceased to be Director on 19 Dec 2020. Shailja Chandramani Meshram was appointed as Additional Director on 05 Dec 2020. Chandramani Suryabhan Meshram was appointed as Additional Director on 26 Nov 2020. Impaler Pharmaceuticals has 4 board changes on record in total.
The registered office of Impaler Pharmaceuticals is at 680 Plot No 12 – A Rambag Layout Behind Shushila, Nagpur, Maharashtra, India – 440003.
Impaler Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.